SCHEMBL5887353

SCHEMBL5887353

COC1=CC[CH]C(c2cccc(C)c2)=C1c1ccc(C)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ACHE P22303 1/20 0.34
KDM4E B2RXH2 2/20 0.33
NPC1 O15118 1/20 0.33
TSHR P16473 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HTR2C P28335 1/20 0.33
ALKBH3 Q96Q83 1/20 0.33
HSD17B2 P37059 1/20 0.32
TP53 P04637 1/20 0.32
CTSD P07339 1/20 0.31
BACE1 P56817 1/20 0.31
GALR1 P47211 1/20 0.31
FYN P06241 1/20 0.31
CLK4 Q9HAZ1 1/20 0.31
DYRK1B Q9Y463 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5887199 0.91 KMT2A (0.35) MEN1KMT2AL3MBTL1ACHENPC1
SCHEMBL5887285 0.89 ALKBH3 (0.44) MEN1KMT2AL3MBTL1ACHEKDM4E
SCHEMBL5887105 0.88 ESR2 (0.35) NPC1TSHRSMN1; SMN2TP53
SCHEMBL5887320 0.87 ACHE (0.33) KMT2AACHENPC1RAB9AHSD17B10
SCHEMBL6047593 0.82 ALKBH3 (0.36) HSD17B10ALKBH3
SCHEMBL5887287 0.81 ACHE (0.46) MEN1KMT2AACHEKDM4ENPC1
SCHEMBL5887347 0.81 MEN1 (0.35) MEN1KMT2AHTR2CTP53
SCHEMBL5887311 0.80 KMT2A (0.36) MEN1KMT2AL3MBTL1ACHEKDM4E
SCHEMBL5887143 0.80 PTGS2 (0.35) MEN1KMT2ARAB9AHSD17B10ALKBH3
SCHEMBL5887155 0.80 NOTUM (0.36) NPC1TSHRSMN1; SMN2CTSDBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7037931-B2 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-02 US claimed
JP-2006501194-A 2006-01-12 JP claimed
EP-1525190-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-04-27 EP claimed
WO-2004007463-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2004-01-22 WO claimed